Upregulation of miRNA-23a-3p rescues high glucose-induced cell apoptosis and proliferation inhibition in cardiomyocytes

Abstract

Maternal hyperglycemia potentially inhibits the development of the fetal heart by suppressing cardiomyocyte proliferation and promoting apoptosis. Different studies have indicated that miRNAs are key regulators of cardiomyocyte proliferation, differentiation, and apoptosis and play a protective role in a variety of cardiovascular diseases. However, the biological function of miRNA-23a in hyperglycemia-related cardiomyocyte injury is not fully understood. The present study investigated the effect of miRNA-23a-3p on cell proliferation and apoptosis in a myocardial injury model induced by high glucose. H9c2 cardiomyocytes were exposed to high glucose to establish an in vitro myocardial injury model and then transfected with miRNA-23a-3p mimics. After miRNA-23a-3p transfection, lens-free microscopy was used to dynamically monitor cell numbers and confluence and calculate the cell cycle duration. CCK-8 and EdU incorporation assays were performed to detect cell proliferation. Flow cytometry was used to measured cell apoptosis. Upregulation of miRNA-23a-3p significantly alleviated high glucose-induced cell apoptosis and cell proliferation inhibition (p < 0.01 and p < 0.0001, respectively). The cell cycle of the miRNA-23a-3p mimics group was significantly shorter than that of the negative control group (p < 0.01). The expression of cell cycle–activating and apoptosis inhibition-associated factors Ccna2, Ccne1, and Bcl-2 was downregulated by high glucose and upregulated by miRNA-23a-3p overexpression in high glucose-injured H9c2 cells. miRNA-23a-3p mimics transfection before high glucose treatment had a significantly greater benefit than transfection after high glucose treatment (p < 0.0001), and the rescue effect of miRNA-23a-3p increased as the concentration increased. This study suggests that miRNA-23a-3p exerted a dose- and time-dependent protective effect on high glucose-induced H9c2 cardiomyocyte injury.

Regulatory role of miRNA‑23a in diabetic retinopathy

“…In the present study, results from bioinformatics prediction indicated that miRNA-23a was an upstream miRNA regulating VEGF, with similar and highly conservative sequences within the targeted regions in human and rat models. miRNA-23a is widely involved in the regulation of various physiological and pathological processes in the body, which plays an important role in the cellular differentiation (45)(46)(47). miRNA-23a has been shown to be involved in the formation of skeletal muscle, hematopoietic cell differentiation and bone metabolism (48).…”

miR‐6718‐5p and miR‐4329 can be used as potential biomarkers for acute myocardial infarction

“…Many researchers have focused on how to prevent or reduce myocardial injury. Many studies have found that cell‐derived exosomes can carry and transfer myocardial protective miRNAs into damaged cardiomyocytes and have the beneficial effect of cardiac protection 11,12 . They play a critical role in the myocardial injury repair process, but the specific regulatory mechanism of miRNAs in AMI remains unclear.…”

ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1

“…Cell proliferation was analyzed via EdU assay by kFluor555 Click-iT EDU Kit (KeyGen) [ 20 ]. 4 × 10 4 cells were plated in the 96-well plates overnight and cell transfection was performed for 48 h, followed by cell labeling with EDU working solution.…”